•Alper B. Aspirin therapy does not prevent CHD in women. Clin Advisor 2005;6:104-7.
•Diamond S, Wenzel R. Intramuscular droperidol for acute migraine: cause for concern? Consultant 2005;45:222-4.
•Feeman WE. High LDL and HDL: implications in a perimenopausal woman. Consultant 2005;45:726.
•Frykberg RG. Diabetic foot ulcers: keys to prompt, aggressive therapy. Consultant 2005;45:301-9.
•Guthrie R. Should you set lower LDL targets? Clinical Advisor 2005;6:20-30.
•Levin RI. The puzzle of aspirin and sex. N Engl J Med 2005;352:1366-8.
•Morris C. Comorbidities increase hypertension dangers. Clinical Advisor 2005;3:46-8.
•Nash D. Lowering cholesterol in high-risk patients with low statin tolerance. Consultant 2005;45-151.
•Nash DT. C-reactive protein: a promising new marker of cardiovascular risk? Consultant 2005;48:453-60.
•Ridker PM, Cook NR, Lee I-M, et al. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med 2005;352:1293-304.
•Silberstein SD. When it comes to migraine prevention, you’ll never know if you don’t ask. Consultant 2005;45:808-9.
•Tepper S. Alternative medicine in migraine: is it ever a good alternative? Consultant 2005;45:662-6.
•Vidt DG. Weight loss benefits go beyond BP control. Consultant 2005;45:451-2.
•Wright W. Practitioners on the front line: assessing patients for migraine. Clinical Advisor 2005:4(Suppl):3-8.